Skip to Main Content

Author Details

Larisa H Cavallari
Department of Pharmacotherapy and Translational Research, University of Florida
2004
191
39
PMIDPaper TitleJournal TitlePublished Year
38013396Feasibility of preemptive pharmacogenetic testing and improvement of medication treatment satisfaction among medically underserved patients.Clin Transl Sci2024
36321873Local Ancestry-Informed Candidate Pathway Analysis of Warfarin Stable Dose in Latino Populations.Clin Pharmacol Ther2023
37716912Clinician Response to Pharmacogenetic Clinical Decision Support Alerts.Clin Pharmacol Ther2023
37705211A pilot study to identify pharmacogenomic and clinical risk factors associated with opioid related falls and adverse effects in older adults.Clin Transl Sci2023
37698371CYP2D6-guided opioid therapy for adults with cancer pain: A randomized implementation clinical trial.Pharmacotherapy2023
37645439Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States.Front Pharmacol2023
37680199Lessons from clinical implementation of a preemptive pharmacogenetic panel as part of a testing pilot program with an employer-sponsored medical plan.Front Genet2023
37084734Use of a multi-gene pharmacogenetic panel reduces adverse drug effects.Cell Rep Med2023
37303270An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers.Clin Pharmacol Ther2023
37166395Pharmacist-guided pharmacogenetic service lowered warfarin-related hospitalizations.Pharmacogenomics2023
37166240Implementation of CYP2C19 genotyping to guide proton pump inhibitor use at an academic health center.Am J Health Syst Pharm2023
37067798Assessing the Clinical Treatment Dynamics of Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary Intervention in the US.JAMA Netw Open2023
36588476Pharmacogenetics of P2Y<sub>12</sub> receptor inhibitors.Pharmacotherapy2023
36507737Genomewide Association Study Identifies Copy Number Variants Associated With Warfarin Dose Response and Risk of Venous Thromboembolism in African Americans.Clin Pharmacol Ther2023
36898938Genotype-Guided Selection of Antiplatelet Therapy: The Evidence Moves East.JACC Cardiovasc Interv2023
34562070Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy.Clin Transl Sci2022
35429163Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World Investigation.Clin Pharmacol Ther2022
35568931Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy.Implement Sci Commun2022
35488487A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence.Clin Transl Sci2022
35784584Pharmacogenetics: A Precision Medicine Approach to Combatting the Opioid Epidemic.J Am Coll Clin Pharm2022
35389962Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantation.Pharmacogenet Genomics2022
36447952Characterizing <i>OPRM1</i> DNA methylation in prescription opioid users with chronic musculoskeletal pain.Pain Rep2022
36589694How to Implement a Pharmacogenetics Service at your Institution.J Am Coll Clin Pharm2022
35999027Identification of a SGCD ÿ Discrimination Interaction Effect on Systolic Blood Pressure in African American Adults in the Jackson Heart Study.Am J Hypertens2022
36368780Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing.Clin Lab Med2022
36082121Evaluation of race and ethnicity disparities in outcome studies of <i>CYP2C19</i> genotype-guided antiplatelet therapy.Front Cardiovasc Med2022
35156424<i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings.J Am Heart Assoc2022
34918066Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.Eur Heart J2022
35001645Changing from mandatory to optional genotyping results in higher acceptance of pharmacist-guided warfarin dosing.Pharmacogenomics2022
35108398Warfarin Dosing in Patients With CYP2C9*5 Variant Alleles.Clin Pharmacol Ther2022
34642472Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers.Pharmacogenomics J2022
34713976β1-receptor polymorphisms and junctional ectopic tachycardia in children after cardiac surgery.Clin Transl Sci2022
32897581Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.Clin Pharmacol Ther2021
33824430Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model.Pharmacogenomics J2021
33721568Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study.Curr Probl Cardiol2021
34408773Cox-sMBPLS: An Algorithm for Disease Survival Prediction and Multi-Omics Module Discovery Incorporating <i>Cis</i>-Regulatory Quantitative Effects.Front Genet2021
34483679Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management.Pharmgenomics Pers Med2021
34776967Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans.Front Pharmacol2021
34569641NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo-DHF trial.Pharmacotherapy2021
34834578Utilizing a Human-Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support.J Pers Med2021
33993817Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations.Expert Rev Clin Pharmacol2021
34101169Moving Pharmacogenetics Into Practice: It's All About the Evidence!Clin Pharmacol Ther2021
34075203Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease.Pharmacogenomics J2021
34154818Corrigendum to "Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study". [Current Problems in Cardiology Volume 46, Issue 6, June 2021, 100816].Curr Probl Cardiol2021
33953382Pharmacogenetics to guide cardiovascular drug therapy.Nat Rev Cardiol2021
34231197How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A Tutorial.Clin Pharmacol Ther2021
34282303Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.Genet Med2021
34109627PharmVar GeneFocus: CYP2C9.Clin Pharmacol Ther2021
33428770Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.Clin Pharmacol Ther2021
33166056Acceptability, Feasibility, and Utility of Integrating Pharmacogenetic Testing into a Child Psychiatry Clinic.Clin Transl Sci2021
  • 1 - 50 of 191

Recommended Authors

Alyson L Dickson
Vanderbilt University Medical Center
Career Start Year 2019
Number of shared co-authors 8
Moneeza K Siddiqui
University of Dundee, Ninewells Hospital and Medical School
Career Start Year 2016
Number of shared co-authors 14
Xiaoxi Yao
Department of Cardiovascular Medicine Mayo Clinic Rochester MN.
Career Start Year 2014
Number of shared co-authors 0
Seyed Hamidreza Mahmoudpour
Institute for Medical Biostatistics, University Medical Center Mainz
Career Start Year 2013
Number of shared co-authors 14
Megan M Shuey
Vanderbilt University Medical Center
Career Start Year 2013
Number of shared co-authors 7
Gillian C Bell
Mission Health Personalized Medicine & Pharmacogenomics Program
Career Start Year 2011
Number of shared co-authors 46
Omri Gottesman
Icahn School of Medicine at Mount Sinai
Career Start Year 2011
Number of shared co-authors 25
Jessica Minnier
Louis Stokes Cleveland VA Medical Center Cleveland
Career Start Year 2010
Number of shared co-authors 0
QiPing Feng
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 27
James S Floyd
Cardiovascular Health Research Unit, University of Washington
Career Start Year 2008
Number of shared co-authors 9
Nathan E Wineinger
Scripps Research Translational Institute, The Scripps Research Institute
Career Start Year 2008
Number of shared co-authors 0
Quinn S Wells
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 34
Terrie Kitchner
Center for Precision Medicine Research, Marshfield Clinic Research Institute
Career Start Year 2007
Number of shared co-authors 29
Suzette J Bielinski
Mayo Clinic
Career Start Year 2005
Number of shared co-authors 33
Joshua J Gagne
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 3
Rubin Lubomirov
Clinical Development
Career Start Year 2003
Number of shared co-authors 0
Thomas J Urban
Eshelman School of Pharmacy, University of North Carolina
Career Start Year 2003
Number of shared co-authors 2
Alex S F Doney
University of Dundee. Ninewells Hospital
Career Start Year 2002
Number of shared co-authors 24
Sook Wah Yee
University of California San Francisco
Career Start Year 2001
Number of shared co-authors 26
Gregory D Jenkins
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 10
Xin-Qun Wang
University of Virginia Health System
Career Start Year 2001
Number of shared co-authors 3
Pedro J Caraballo
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 19
Linnea M Baudhuin
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 6
Lara M Mangravite
Children's Hospital Oakland Research Institute
Career Start Year 1998
Number of shared co-authors 6
Jonathan D Mosley
Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 25
Nicholas L Smith
University of Washington
Career Start Year 1994
Number of shared co-authors 23
Deanna L Kroetz
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 20
Bruce C Carleton
BC Children's Hospital Research Institute
Career Start Year 1991
Number of shared co-authors 9
Daniel E Singer
Clinical Epidemiology Unit, Massachusetts General Hospital
Career Start Year 1978
Number of shared co-authors 1
Philip T Sager
Inc., Canada Cardiovascular Research Institute, Stanford University
Career Start Year 1975
Number of shared co-authors 2

Collaborators

Julie A Johnson
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 54
Taimour Y Langaee
Center for Pharmacogenomics and Precision Medicine, University of Florida
Co-authored papers 27
Nita A Limdi
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 23
Amber L Beitelshees
University of Maryland School of Medicine
Co-authored papers 16
Kristin W Weitzel
Department of Pharmacotherapy & Translational Research, University of Florida
Co-authored papers 15
Donald M Smith
Georgetown University Medical Center
Co-authored papers 14
Amanda R Elsey
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 13
Stuart A Scott
Stanford University
Co-authored papers 13
Emily J Cicali
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 13
Teri E Klein
Stanford University
Co-authored papers 13
Sony Tuteja
University of Pennsylvania Perelman School of Medicine
Co-authored papers 12
Nihal El Rouby
Department of Pharmacy Practice and Administrative Sciences, University of Cincinnati
Co-authored papers 12
Victoria M Pratt
Indiana University School of Medicine
Co-authored papers 9
Rick A Kittles
Morehouse School of Medicine
Co-authored papers 9
Josh F Peterson
Vanderbilt University Medical Center
Co-authored papers 9
James K Hicks
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 8
Caitrin W McDonough
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 8
Sara L Van Driest
National Institutes of Health
Co-authored papers 8
Rhonda M Cooper-DeHoff
College of Medicine, University of Florida
Co-authored papers 7
Michelle Whirl-Carrillo
Stanford University
Co-authored papers 7
Russ B Altman
Stanford University
Co-authored papers 7
Joshua C Denny
Vanderbilt University
Co-authored papers 6
Karen E Weck
University of North Carolina at Chapel Hill
Co-authored papers 6
Eric R Gamazon
Vanderbilt University Medical Center
Co-authored papers 6
Dan M Roden
Vanderbilt University Medical Center
Co-authored papers 5
Marc B Rosenman
Northwestern University Feinberg School of Medicine
Co-authored papers 5
Guilherme Suarez-Kurtz
Instituto Nacional de Cancer
Co-authored papers 5
Stephen E Kimmel
University of Florida
Co-authored papers 5
Howard L McLeod
Center for Precision Medicine and Functional Genomics, Utah Tech University
Co-authored papers 5
Steven A Lubitz
Cardiovascular Research Center, Massachusetts General Hospital
Co-authored papers 5
Release 1.2